Received Feb 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | NA4459 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 247L3 | IM / LA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 553E2 | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Z002437 | IM / RA |
No adverse event
UTI 02/02/26; Trichomonas 02/02/26; Acute Bronchitis 01/15/26
Bilateral carpal tunnel syndrome, essential hypertension, Chronic low back pain, hemorrhoids, adjustment disorder with mixed anxiety and depressed mood, opioid use disorder, moderate, in sustained remission, PTSD, Dorsalgia, Pelvic muscle wasting, Long-term use of opiate analgesic, Anterior cruciate ligament compete tear, Trigger thumb of right hand
Albuterol inhaler PRN, Benzonatate 100mg PRN, Suboxone 8-2mg BID, Wellbutrin 300mg QD, Zyrtec 10mg QD, Calcium 50,000 unit 1xweek, Flonase PRN, Neurontin 800mg TID, Microzide 12.5mg QD, Motrin 400mg PRN, Zestril 30mg QD
Lentils
N/A